307. Rapid Resistance Development to Three Antistaphylococcal Therapies in Daptomycin-tolerant Staphylococcus aureus Bacteremia

Tekijä Miller, Christopher R, Monk, Jonathan, Berti, Andrew David
Julkaisussa Open Forum Infect Dis (2020)

Reversible Redox Effect on Gas Permeation of Cobalt Doped Ethoxy Polysiloxane (ES40) Membranes

Tekijä Miller, Christopher R., Wang, David K., Smart, Simon, Diniz da Costa, João C.
Julkaistu 2013

Nanoscale assembly of lanthanum silica with dense and porous interfacial structures

Tekijä Ballinger, Benjamin, Motuzas, Julius, Miller, Christopher R., Smart, Simon, Diniz da Costa, João C.
Julkaisussa Sci Rep (2015)

613. Suppression of Daptomycin Resistance Development in Staphylococcus aureus Is a Class Effect of β-Lactams and Is Independent of Daptomycin–β Lactam Synergy

Tekijä Miller, Christopher R, Dey, Somrita, Smolenski, Paula, Kulkarni, Pushkar S, Baines, Sarah L, David. Berti, Andrew
Julkaisussa Open Forum Infect Dis (2019)

596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis

Tekijä Miller, Christopher R, Dey, Somrita, Smolenski, Paula, Kulkarni, Pushkar S, Sakoulas, George, Monk, Jonathan M, Szubin, Richard, David. Berti, Andrew
Julkaisussa Open Forum Infect Dis (2019)

Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis

Tekijä Miller, Christopher R., Dey, Somrita, Smolenski, Paula D., Kulkarni, Pushkar S., Monk, Jonathan M., Szubin, Richard, Sakoulas, George, Berti, Andrew D.
Julkaisussa Antimicrob Agents Chemother (2020)

556. Evaluation of Hydroxychloroquine-based Combination Therapies for the Treatment of COVID-19

Tekijä Berti, Andrew David, Kale-Pradhan, Pramodini, Giuliano, Christopher, Aprilliano, Bianca, Miller, Christopher R, Alyashae, Basma, Bhargava, Ashish, Johnson, Leonard B
Julkaisussa Open Forum Infect Dis (2020)